POULTON JEFFREY V. (Chief Financial Officer) sold 3.3% of their position (2.21K shares) of ALNYLAM PHARMACEUTICALS, INC. on the open market
Open‑market sale worth $722.8K — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
Common Stock
Shares
+4.77K
Price / share
—
Trade value
—
% of position
Common Stock
Shares
−65.00
Price / share
$323.62
Trade value
$21.04K
% of position
Common Stock
Shares
−124.00
Price / share
$324.65
Trade value
$40.26K
% of position
Common Stock
Shares
−356.00
Price / share
$325.63
Trade value
$115.92K
% of position
Common Stock
Shares
−541.00
Price / share
$326.81
Trade value
$176.80K
% of position
Common Stock
Shares
−454.00
Price / share
$327.67
Trade value
$148.76K
% of position
Common Stock
Shares
−138.00
Price / share
$328.71
Trade value
$45.36K
% of position
Common Stock
Shares
−234.00
Price / share
$329.71
Trade value
$77.15K
% of position
Common Stock
Shares
−112.00
Price / share
$330.85
Trade value
$37.06K
% of position
Common Stock
Shares
−129.00
Price / share
$331.93
Trade value
$42.82K
% of position
Common Stock
Shares
−53.00
Price / share
$332.64
Trade value
$17.63K
% of position
Net shares
+2.56K
Net value
-$722.80K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 3/2/2026 | A · Award | +4.77K | — | — | 7.7% | 61.71K | 66.48K |
| Common Stock Direct | 3/2/2026 | S · Sale | −65.00 | $323.62 | $21.04K | 0.1% | 66.48K | 66.41K |
| Common Stock Direct | 3/2/2026 | S · Sale | −124.00 | $324.65 | $40.26K | 0.2% | 66.41K | 66.29K |
| Common Stock Direct | 3/2/2026 | S · Sale | −356.00 | $325.63 | $115.92K | 0.5% | 66.29K | 65.93K |
| Common Stock Direct | 3/2/2026 | S · Sale | −541.00 | $326.81 | $176.80K | 0.8% | 65.93K | 65.39K |
| Common Stock Direct | 3/2/2026 | S · Sale | −454.00 | $327.67 | $148.76K | 0.7% | 65.39K | 64.94K |
| Common Stock Direct | 3/2/2026 | S · Sale | −138.00 | $328.71 | $45.36K | 0.2% | 64.94K | 64.80K |
| Common Stock Direct | 3/2/2026 | S · Sale | −234.00 | $329.71 | $77.15K | 0.4% | 64.80K | 64.57K |
| Common Stock Direct | 3/2/2026 | S · Sale | −112.00 | $330.85 | $37.06K | 0.2% | 64.57K | 64.45K |
| Common Stock Direct | 3/2/2026 | S · Sale | −129.00 | $331.93 | $42.82K | 0.2% | 64.45K | 64.33K |
| Common Stock Direct | 3/2/2026 | S · Sale | −53.00 | $332.64 | $17.63K | 0.1% | 64.33K | 64.27K |
| Total | +2.56K | -$722.80K | ||||||
Stock Option (right to buy)
Common Stock
10.48K shares
Shares
+10.48K
Strike price
325.07
Held after
10.48K
Exercisable
—
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock Option (right to buy) Direct | Common Stock10.48K shares | 3/2/2026 | A · Award | +10.48K | 325.07 | — | 10.48K |
Common Stock
Indirect| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 57.00 | Indirect |
| Total | 57.00 | 57.00 indirect |